Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pathology, Research and Practice

• Publication date

  2011-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.prp.2011.01.001PMID 21300445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New techniques in dermatopathology that help to diagnose and prognosticate melanoma.

  2009cited by this paper
• G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas

  2008cited by this paper
• ROC1 Protein, Cell Cycle and Cancer

  2008cited by this paper
• The Significance of Ki-67 Proliferative Index and Cyclin D1 Expression of Dysplastic Nevi in the Biologic Spectrum of Melanocytic Lesions

  2007cited by this paper
• Imuno-histoquímica para identificação de células neoplásicas no infiltrado ativo de melanomas finos

  2006cited by this paper
• The role of cell cycle regulatory proteins in the pathogenesis of melanoma

  2006cited by this paper
• Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.

  2005cited by this paper
• Distinct sets of genetic alterations in melanoma.

  2005cited by this paper
• Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer

  2003influential reference
• Classifying melanocytic tumors based on DNA copy number changes.

  2003cited by this paper
• Caenorhabditis elegans RBX1 is essential for meiosis, mitotic chromosomal condensation and segregation, and cytokinesis

  2003cited by this paper
• Activation of UBC5 Ubiquitin-conjugating Enzyme by the RING Finger of ROC1 and Assembly of Active Ubiquitin Ligases by All Cullins*

  2002cited by this paper
• A Molecular Basis for Stabilization of the von Hippel-Lindau (VHL) Tumor Suppressor Protein by Components of the VHL Ubiquitin Ligase*

  2002cited by this paper
• Cyclin D1 is a candidate oncogene in cutaneous melanoma.

  2002cited by this paper
• Role of the F-Box Protein Skp2 in Adhesion-Dependent Cell Cycle Progression

  2001cited by this paper
• Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.

  2001cited by this paper
• In vitro ubiquitination of cyclin D1 by ROC1–CUL1 and ROC1–CUL3

  2001cited by this paper
• The Conserved RING-H2 Finger of ROC1 Is Required for Ubiquitin Ligation*

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• Ubiquitin‐mediated proteolysis: biological regulation via destruction

  2000cited by this paper
• The ubiquitin‐mediated proteolytic pathway: Mode of action and clinical implications

  2000cited by this paper
• Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34.

  1999cited by this paper
• Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha.

  1999cited by this paper
• SCF and Cullin/Ring H2-based ubiquitin ligases.

  1999cited by this paper
• Genomic organization and expression of the ubiquitin-proteasome complex-associated protein Rbx1/ROC1/Hrt1.

  1999cited by this paper
• Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.

  1999cited by this paper
• ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.

  1999cited by this paper
• Recruitment of a ROC1–CUL1 Ubiquitin Ligase by Skp1 and HOS to Catalyze the Ubiquitination of IκBα

  1999cited by this paper
• Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer

  1999cited by this paper
• Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

  1998cited by this paper
• SCF and APC: the Yin and Yang of cell cycle regulated proteolysis.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

  1998cited by this paper

• Absence of Differential Cyclin D1 Immunohistochemical Protein Expression in Nevi and Melanoma Evaluated by Digital Image Analysis

  2022cites this paper
• Clinicopathological and prognostic role of ROC1 in neoplasms: A PRISMA-compliant systematic review and meta-analysis

  2022cites this paper
• Prognostic and Clinicopathological Significance of CCND1/Cyclin D1 Upregulation in Melanomas: A Systematic Review and Comprehensive Meta-Analysis

  2021cites this paper
• An update on the implications of cyclin D1 in melanomas

  2020cites this paper
• Expression of Ring Box-1 protein and its relationship with Fuhrman grade and other clinical-pathological parameters in renal cell cancer.

  2019cites this paper
• Targeting the Ubiquitin Proteasome System in Cancer

  2018cites this paper
• The relation between Ring Box-1 protein overexpression and tumor grade and stage in bladder urothelial cell carcinoma

  2017cites this paper
• E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.

  2015cites this paper
• Cascade profiling of the ubiquitin-proteasome system in cancer

  2015cites this paper
• Multispectral Imaging

  2014cites this paper
• Prognostic impact of RING box protein-1 (RBX1) expression in gastric cancer

  2014cites this paper
• Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

  2013cites this paper
• Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma

  2013cites this paper
• Knockdown of Regulator of Cullins-1 (ROC1) Expression Induces Bladder Cancer Cell Cycle Arrest at the G2 Phase and Senescence

  2013cites this paper
• Overexpression of RING box protein‐1 (RBX1) associated with poor prognosis of non‐muscle‐invasive bladder transitional cell carcinoma

  2013cites this paper
• The role of CCND1 alterations during the progression of cutaneous malignant melanoma

  2012cites this paper